The FDA has approved the first interchangeable biosimilar for adalimumab (Humira), a TNF inhibitor commonly taken for spondyloarthritis…
Among adults with rheumatic diseases including spondyloarthritis, who received COVID-19…
The incidence of ankylosing spondylitis (AS) did not differ significantly…
Fibromyalgia, a chronic pain condition commonly thought to originate in the brain,…
The FDA said the trial results showed elevated risks of…
Those with moderately to severely compromised immune systems who received…
Input your search keywords and press Enter.
